India  

Uzbekistan cough syrup case: Centre issues first statement, says probe underway | Oneindia News*News

Video Credit: Oneindia - Duration: 01:46s - Published
Uzbekistan cough syrup case: Centre issues first statement, says probe underway | Oneindia News*News

Uzbekistan cough syrup case: Centre issues first statement, says probe underway | Oneindia News*News

Today, Union health minister Mansukh Mandaviya said the Central Drugs Standard Control Organisation (CDSCO) has been in touch with Uzbekistan's national drugs regulator since December 27.

This comes as India’s central government's first statement on the deaths of children in Uzbekistan after being given Doc-1 Max, a cough syrup made by Marion Biotech, an Indian manufacturer.

#Uzbekistan #Indiancoughdrop #Doc1Max


You Might Like


💡 newsR Knowledge: Other News Mentions

Mansukh Mandaviya Mansukh Mandaviya Indian politician (born 1972)

Health Minister launches India’s first nasal COVID-19 vaccine ‘iNCOVACC’ | Oneindia News [Video]

Health Minister launches India’s first nasal COVID-19 vaccine ‘iNCOVACC’ | Oneindia News

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first nasal COVID-19 vaccine - 'iNCOVACC' on Thursday. The nasal COVID-19 vaccine has been made by Bharat Biotech. A primary two-dose schedule and a heterologous booster dosage for 'iNCOVACC' have been approved. #iNCOVACC #NasalCovidVaccine #BharatBiotech

Credit: Oneindia    Duration: 01:58Published

Uzbekistan Uzbekistan Country in Central Asia, bordered with five countries

A 6.8 & 2.7 magnitude earthquake strikes Delhi-NCR region,Know what people have to say|Oneindia News [Video]

A 6.8 & 2.7 magnitude earthquake strikes Delhi-NCR region,Know what people have to say|Oneindia News

Strong earthquake tremors were felt in northern India including the Delhi-NCR region, Punjab and Haryana. According to reports, the earthquake measuring 6.8 on the Richter scale hit countries including Turkmenistan, India, Kazakhstan, Pakistan, Tajikistan, Uzbekistan, China, Afghanistan, and Kyrgyzstan. The epicenter is believed to be 90 km from Kalafgan in Afghanistan. A day after north India felt tremors of the strong 6.8 magnitude earthquake with the epicentre in Afghanistan, the National Centre for Seismology has recorded 2.7 magnitude earthquake in the national capital on 22nd March. Watch to know what people had to say about the earthquake happening around. Comment down below your thoughts! Like, share and subscribe. #Earthquake #DelhiEarthquake #NCR

Credit: Oneindia    Duration: 03:20Published
Judo: Uzbekistan takes two more golds at the Tashkent Grand Slam 2023 [Video]

Judo: Uzbekistan takes two more golds at the Tashkent Grand Slam 2023

Uzbek's Davlat Bobonov was on fire throughout the day on day 3 of the Tashkent Grand Slam in Uzbekistan and Alisher Yusupov also took gold after she countered Saito Tatsuru of Japan.

Credit: euronews (in English)    Duration: 03:00Published
Judo: Uzbekistan takes gold on the second day of Tashkent Grand Slam 2023 [Video]

Judo: Uzbekistan takes gold on the second day of Tashkent Grand Slam 2023

The second day of the Tashkent Grand Slam saw middleweight judoko's perform exciting judo in Uzbekistan with Japan's Megumi Horikawa take home gold - her fourth grand slam gold medal.

Credit: euronews (in English)    Duration: 03:00Published
Korea takes gold at the World Judo Tour in Uzbekistan [Video]

Korea takes gold at the World Judo Tour in Uzbekistan

People attending the first day of the World Judo Tour in Uzbekistan were treated to an unforgettable display of skill and sportsmanship.

Credit: euronews (in English)    Duration: 03:00Published
'Artificial Tears': US CDC issues advisory against India-made eye-drop | Explainer | Oneindia News [Video]

'Artificial Tears': US CDC issues advisory against India-made eye-drop | Explainer | Oneindia News

The US FDA has issued advisory against using ‘Artificial Tears’…an eye drop manufactured by an Indian pharmaceutical company. This is the third such incident in the recent times in which Indian pharmaceutical companies have been in the crosshairs of health authorities. Just few months back, a controversy had erupted over the death of 66 children in Gambia after taking cough syrup imported from India. Then, towards the end of December, Uzbekistan had also claimed that 18 of 21 children with acute respiratory diseases died after ingesting Dok-1 Max syrup…a syrup that was manufactured and exported to Uzbekistan. In this video, we take a look at the possible reasons why the US FDA has issued caution over an India-made eye drop. But before that, don’t forget to like, share and subscribe to Oneindia #USFDA#artificialtearseyedrop #USAbansindiaeyedrop

Credit: Oneindia    Duration: 03:43Published

Related videos from verified sources

India made cough syrup kills 18 children in Uzbekistan, probe ordered| Oneindia News *News [Video]

India made cough syrup kills 18 children in Uzbekistan, probe ordered| Oneindia News *News

Uzbekistan said that 18 children lost their lives after consuming Indian medicine. India has now ordered a probe into the matter. #Uzbekistan #Indiancoughdrop #Doc1Max

Credit: Oneindia     Duration: 01:37Published
India: BF.7 variant behind the sudden surge in China Covid cases found | Oneindia News *News [Video]

India: BF.7 variant behind the sudden surge in China Covid cases found | Oneindia News *News

The much feared Omicron BF.7 variant has left China in turmoil once again. The country has reported 3 confirmed cases of the BF.7 variant so far. The first case of BF.7 in India was detected in October..

Credit: Oneindia     Duration: 03:05Published
Parliament Winter Session: Piyush Goyal slams Mallikarjun Kharge over ‘dog’ remarks | Oneindia News [Video]

Parliament Winter Session: Piyush Goyal slams Mallikarjun Kharge over ‘dog’ remarks | Oneindia News

Row erupts in Rajya Sabha over Congress chief Mallikarjun Kharge’s ‘dog’ remarks; Dense fog engulfs parts of North India, IMD issues poor visibility alert in 4 states; ‘Radicalised Islamists’..

Credit: Oneindia     Duration: 02:51Published